SPH Notice

12788819_1
Disclosure of movement of 1% or more in substantial holding
or change in nature of relevant interest, or both
Sections 277 and 278, Financial Markets Conduct Act 2013
To NZX Limited
and
To Promisia Healthcare Limited
Relevant event being disclosed: Movement of 1% or more in substantial holding
Date of relevant event: 25 March 2021
Date this disclosure made: 25 March 2021
Date last disclosure made: 28 January 2021
Substantial product holder(s) giving disclosure
Full name(s): Thomas David Brankin and Michael John Kirwin Lay as trustees of the
Brankin Family Interest Trust
Summary of substantial holding
Class of quoted voting products: Ordinary Shares
Summary for Thomas David Brankin and Michael John Kirwin Lay as trustees of the
Brankin Family Interest Trust
For this disclosure,—
(a) total number held in class: 10,126,082,611
(b) total in class: 17,989,480,784
(c) total percentage held in class: 56.289%
For last disclosure,—
(a) total number held in class: 9,112,099,278
(b) total in class: 16,901,797,451
(c) total percentage held in class: 53.364%
Details of transactions and events giving rise to relevant event
Details of the transactions or other events requiring disclosure:
The following allotments of fully paid ordinary shares in Promisia Healthcare Limited
approved by shareholders on 24 March 2021 in accordance with NZX Listing Rules:
 allotment of 18,983,333 ordinary shares to Thomas David Brankin and Michael John
Kirwin Lay as trustees of the Brankin Family Interest Trust on 25 March 2021 at an
issue price of $0.001 per share for the capitalisation of directors fees owing to
Thomas David Brankin;

12788819_1
 allotment of 300,000,000 ordinary shares to Thomas David Brankin and Michael
John Kirwin Lay as trustees of the Brankin Family Interest Trust on 25 March 2021
for an issue price of $0.001 per share for cash; and
 allotment of 695,000,000 ordinary shares to Thomas David Brankin and Michael
John Kirwin Lay as trustees of the Brankin Family Interest Trust on 25 March 2021
at an issue price of $0.001 per share for the part capitalisation of amounts owing to
Thomas David Brankin and Michael John Kirwin Lay as trustees of the Brankin
Family Interest Trust.
Details after relevant event
Details for Thomas David Brankin and Michael John Kirwin Lay as trustees of the Brankin
Family Interest Trust
Nature of relevant interest(s): Registered holder of shares in Promisia Healthcare Limited
as trustee of the Brankin Family Interest Trust
For that relevant interest,—
(a) number held in class: 10,126,082,611
(b) percentage held in class: 56.289%
(c) current registered holder(s): Thomas David Brankin and Michael John Kirwin Lay as
trustees of the Brankin Family Interest Trust
(d) registered holder(s) once transfers are registered: N/A
Additional information
Address(es) of substantial product holder(s): 105 Messenger Terrace, Oakura, New
Zealand
Contact details: Stephen Underwood, +64 27 499 3387
Nature of connection between substantial product holders: Thomas David Brankin and
Michael John Kirwin Lay are trustees of the Brankin Family Interest Trust.
Name of any other person believed to have given, or believed to be required to give, a
disclosure under the Financial Markets Conduct Act 2013 in relation to the financial
products to which this disclosure relates: N/A
Disclosure has effect for purposes of directors’ and senior managers’ disclosure
Thomas David Brankin is also a director of Promisia Healthcare Limited. This disclosure also
constitutes discloaure for the purposes of the directors’ and senior managers’ disclosure
obligations.
Certification
I, Thomas David Brankin, certify that, to the best of my knowledge and belief, the
information contained in this disclosure is correct and that I am duly authorised to make
this disclosure by all persons for whom it is made.